Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03472560
Title	A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)
Recruitment	Terminated
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Pfizer
Indications	lung non-small cell carcinoma transitional cell carcinoma
Therapies	Avelumab + Axitinib
Age Groups:	adult \| senior
Covered Countries	USA \| POL \| ITA \| HUN \| ESP